5. Protein Metabolism
Learning Objectives
- Describe the four levels of protein structure and explain why structure determines function
- Outline the stages of protein synthesis (transcription and translation) and protein degradation (ubiquitin-proteasome and lysosomal pathways)
- Explain transamination and oxidative deamination, and identify the enzymes and cofactors involved
- Walk through the urea cycle step by step and explain how it disposes of nitrogen safely
- Connect defects in amino acid catabolism and the urea cycle to clinical presentations such as hyperammonemia
- Explain how hormones and nutritional status regulate protein turnover
Quick Answer
Protein metabolism is the set of processes that build, break down, and recycle proteins and their amino acid building blocks. It matters clinically because amino acids are not just used to make new proteins — when broken down, their nitrogen is toxic (as ammonia) unless converted to urea and excreted, and their carbon skeletons feed directly into central energy pathways. The two processes every medical student must master are transamination/deamination (how amino groups are stripped from amino acids) and the urea cycle (how that nitrogen is safely converted to urea). A defect anywhere in the urea cycle causes ammonia to accumulate, producing hyperammonemia and encephalopathy — one of the most commonly tested inborn-error-of-metabolism scenarios.
Structure of Proteins
Protein function depends entirely on protein shape, and shape is built up in four levels of organization.
Primary Structure
The primary structure is simply the linear sequence of amino acids joined by peptide bonds, dictated directly by the mRNA codon sequence. Changing even one amino acid in this sequence can change the entire protein's behavior — the classic example is sickle cell disease, where a single glutamate-to-valine substitution at position 6 of the beta-globin chain causes hemoglobin to polymerize under low oxygen tension.
Secondary Structure
Local, repeating folding patterns — alpha-helices and beta-pleated sheets — stabilized by hydrogen bonds between backbone amide and carbonyl groups. These patterns are the building blocks that get packed together in the next level.
Tertiary Structure
The complete three-dimensional shape of a single polypeptide chain, driven by interactions between amino acid side chains: hydrophobic clustering, disulfide bonds, ionic bonds, and van der Waals forces. Tertiary structure is what creates a functional active site or binding pocket — lose it (denaturation) and the protein loses function even though every peptide bond is intact.
Quaternary Structure
Some proteins are only functional as an assembly of multiple polypeptide subunits. Hemoglobin is the classic teaching example: four subunits (two alpha, two beta) work together cooperatively, so oxygen binding at one subunit increases oxygen affinity at the others.
Protein Synthesis
Every protein in the body is built through two linked processes.
1. Transcription
RNA polymerase copies a gene's DNA sequence into messenger RNA in the nucleus: initiation (polymerase binds the promoter), elongation (RNA is synthesized in the 5' to 3' direction), and termination (a termination signal releases the mRNA).
2. Translation
Ribosomes read the mRNA in codon triplets and assemble the corresponding amino acid chain: initiation (ribosome assembles on the start codon, AUG), elongation (tRNAs deliver amino acids matched to each codon and peptide bonds form), and termination (a stop codon triggers release of the finished polypeptide).
Protein Degradation
Cells constantly break proteins back down into amino acids — this is not wasteful, it is essential quality control and a way to respond to changing metabolic needs.
- Ubiquitin-proteasome pathway: Proteins marked for destruction are tagged with chains of ubiquitin, a small regulatory protein. The tagged protein is unfolded and fed into the proteasome, a barrel-shaped complex that chops it into short peptides. This is the main route for degrading short-lived regulatory proteins (like cyclins) and misfolded proteins.
- Lysosomal (autophagic) degradation: Proteins and even whole organelles are engulfed into lysosomes, where acid hydrolases break them down. This pathway handles bulk turnover during starvation and clears long-lived proteins.
Why it matters: degradation supplies amino acids for gluconeogenesis during fasting, removes misfolded proteins before they aggregate (relevant to neurodegenerative disease), and lets the cell rapidly shut down a signaling pathway by destroying a key protein.
Amino Acid Catabolism: Transamination and Deamination
When amino acids are broken down for energy or converted to glucose, the first problem the cell must solve is what to do with the amino group — free ammonia (NH3) is neurotoxic even at low concentrations. The body solves this in two coordinated steps.
Transamination
Transamination transfers an amino group from an amino acid to a keto acid, without ever releasing free ammonia. The enzymes are aminotransferases (transaminases), and the workhorse cofactor is pyridoxal phosphate (vitamin B6).
- ALT (alanine aminotransferase): alanine + alpha-ketoglutarate → pyruvate + glutamate
- AST (aspartate aminotransferase): aspartate + alpha-ketoglutarate → oxaloacetate + glutamate
Notice the pattern: almost every transamination reaction funnels the amino group onto alpha-ketoglutarate, generating glutamate. This is why glutamate is called the collection point for amino groups — nearly all amino acids can hand off their nitrogen to glutamate before it moves on to the next step. Clinically, ALT and AST are the liver enzymes measured on every metabolic panel; when hepatocytes are damaged, these intracellular enzymes leak into the blood, and elevated levels signal hepatocellular injury.
Oxidative Deamination
Glutamate now carries the collected amino groups. Glutamate dehydrogenase, working in the mitochondria, releases the amino group as free ammonia while regenerating alpha-ketoglutarate:
glutamate + NAD+ (or NADP+) + H2O → alpha-ketoglutarate + NH3 + NADH
This is the one reaction in the body that generates the bulk of free ammonia from amino acid nitrogen, and it happens in a controlled mitochondrial environment specifically so that the ammonia produced can be fed immediately into the urea cycle next door.
The Urea Cycle
The urea cycle takes the toxic ammonia generated by deamination (plus a second nitrogen from aspartate) and converts it into urea — a neutral, water-soluble molecule the kidneys can safely excrete. It runs partly in the mitochondrial matrix and partly in the cytosol of liver cells.
Step by step, in order:
- Carbamoyl phosphate synthetase I (CPS I) combines free ammonia with CO2, consuming 2 ATP, to form carbamoyl phosphate in the mitochondrial matrix. This is the rate-limiting, committed step, and it absolutely requires the allosteric activator N-acetylglutamate (made from acetyl-CoA and glutamate). No N-acetylglutamate means no urea cycle activity.
- Ornithine transcarbamylase (OTC) combines carbamoyl phosphate with ornithine to form citrulline, still inside the mitochondria. Citrulline is then transported out to the cytosol.
- Argininosuccinate synthetase joins citrulline with aspartate (which donates the second nitrogen atom that ends up in urea), consuming ATP, to form argininosuccinate.
- Argininosuccinase (argininosuccinate lyase) cleaves argininosuccinate into arginine and fumarate. That fumarate is a direct link to the TCA cycle — it can be converted to malate and then oxaloacetate, which can regenerate aspartate via transamination, tying the urea cycle to central energy metabolism.
- Arginase cleaves arginine into urea and ornithine. Urea leaves for the kidney and is excreted in urine; ornithine is shuttled back into the mitochondria to start another round.
Net result: two nitrogen atoms (one from free NH3, one from aspartate) plus one CO2 are consumed to make one molecule of urea, at a cost of 4 high-energy phosphate bonds (2 ATP hydrolyzed to 2 ADP + 2 Pi, but one ATP is hydrolyzed all the way to AMP + PPi, which is energetically equivalent to using 2 ATP).
Why This Matters Clinically
If any urea cycle enzyme is deficient (most commonly OTC deficiency, which is X-linked), ammonia backs up because it cannot be converted to urea. The result is hyperammonemia: the classic presentation is a neonate who feeds well for the first day or two, then develops lethargy, poor feeding, vomiting, and progresses to seizures and coma as ammonia crosses the blood-brain barrier and disrupts neuronal energy metabolism and neurotransmission. This is why every sick neonate with unexplained encephalopathy gets an ammonia level checked.
Regulation of Protein Metabolism
- Hormonal regulation: Insulin (fed state) promotes protein synthesis and suppresses protein breakdown; glucagon and cortisol (fasting/stress state) promote proteolysis and release of amino acids for gluconeogenesis.
- Nutritional status: Adequate dietary protein and energy intake support net protein synthesis (positive nitrogen balance); starvation or catabolic illness produces negative nitrogen balance as muscle protein is broken down to supply amino acids for glucose production.
- Cellular signaling: The mTOR pathway integrates amino acid availability and growth factor signaling to promote protein synthesis when nutrients are abundant, and is suppressed during nutrient deprivation.
Key Terms
| Term | Definition | Related Concept |
|---|---|---|
| Transamination | Transfer of an amino group from an amino acid to a keto acid, forming a new amino acid without releasing free ammonia | ALT, AST, pyridoxal phosphate |
| Oxidative deamination | Release of free ammonia from glutamate by glutamate dehydrogenase, regenerating alpha-ketoglutarate | Mitochondria, NAD+/NADP+ |
| Urea cycle | Series of five reactions converting toxic ammonia and CO2 into urea for renal excretion | Hyperammonemia, OTC deficiency |
| Carbamoyl phosphate synthetase I | Rate-limiting urea cycle enzyme; combines NH3 and CO2 using 2 ATP | N-acetylglutamate, mitochondrial matrix |
| N-acetylglutamate | Obligate allosteric activator of carbamoyl phosphate synthetase I | Urea cycle regulation |
| Hyperammonemia | Elevated blood ammonia causing lethargy, vomiting, and encephalopathy | Urea cycle disorders, liver failure |
| Ubiquitin-proteasome pathway | Tags damaged or unneeded proteins with ubiquitin for degradation by the proteasome | Protein turnover, cyclins |
| Primary structure | Linear amino acid sequence of a polypeptide | Peptide bond, genetic code |
| Tertiary structure | Overall 3D folded shape of a single polypeptide chain | Denaturation, active site |
| Nitrogen balance | Comparison of nitrogen intake versus nitrogen excretion | Anabolic/catabolic state, protein turnover |
| mTOR pathway | Signaling pathway that promotes protein synthesis in response to nutrients and growth factors | Anabolism, cell growth |
Common Mistakes
Misconception: Free ammonia is directly incorporated into urea in a single step. Why it's wrong: This skips the actual biochemistry — the urea cycle requires five distinct enzymatic steps across two cellular compartments, and it needs two separate nitrogen donors (free NH3 and aspartate), not just one. Correct understanding: One nitrogen enters as free ammonia via carbamoyl phosphate; the second nitrogen enters later as aspartate reacting with citrulline. Both nitrogens end up in the same urea molecule only after the full five-step cycle completes.
Misconception: Transamination and deamination are the same reaction. Why it's wrong: Transamination moves an amino group from one molecule to another without ever producing free ammonia. Deamination is the separate step that actually releases free ammonia, and it happens almost exclusively via glutamate dehydrogenase acting on glutamate. Correct understanding: Nearly every amino acid first transfers its amino group to alpha-ketoglutarate (making glutamate) via transamination; only then does glutamate undergo oxidative deamination to release NH3.
Misconception: A urea cycle enzyme defect causes disease by urea buildup. Why it's wrong: The clinical danger is not too much urea — it is too little urea production, which lets ammonia accumulate upstream of the block. Correct understanding: Any block in the urea cycle backs up nitrogen as ammonia because the pathway cannot convert it to urea. The toxicity comes from hyperammonemia, not from excess urea (urea itself is relatively harmless and freely excreted by the kidney).
Comparison and Connections
| Feature | Transamination | Oxidative Deamination | Urea Cycle |
|---|---|---|---|
| Where it happens | Cytosol and mitochondria | Mitochondria (mainly liver) | Mitochondria + cytosol (liver only) |
| Key enzyme | ALT, AST (aminotransferases) | Glutamate dehydrogenase | CPS I, OTC, argininosuccinate synthetase, argininosuccinase, arginase |
| Nitrogen fate | Moved between molecules, not released | Released as free NH3 | Free NH3 + aspartate nitrogen combined into urea |
| Cofactor | Pyridoxal phosphate (vitamin B6) | NAD+/NADP+ | ATP, N-acetylglutamate |
| Clinical marker | Elevated ALT/AST in liver injury | Contributes to blood ammonia level | Elevated ammonia in urea cycle disorders |
Practice Questions
Recall
-
Name the five enzymes of the urea cycle in order. Answer guidance: Carbamoyl phosphate synthetase I, ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinase (argininosuccinate lyase), arginase.
-
What cofactor do aminotransferases (ALT and AST) require? Answer guidance: Pyridoxal phosphate, the active form of vitamin B6.
Understanding
-
Why does the body funnel amino groups from many different amino acids onto alpha-ketoglutarate before releasing ammonia? Answer guidance: Centralizing amino group collection onto one molecule (forming glutamate) means the cell only needs one major deamination enzyme (glutamate dehydrogenase) to release free ammonia in a controlled mitochondrial location, rather than many separate deamination reactions scattered throughout the cell.
-
Why is N-acetylglutamate essential for the urea cycle to function at all? Answer guidance: N-acetylglutamate is an obligate allosteric activator of carbamoyl phosphate synthetase I, the first and rate-limiting step. Without it, CPS I stays inactive even if ammonia and CO2 are available, so no carbamoyl phosphate forms and the entire cycle stalls at step one.
Application
-
A newborn is feeding normally for the first 24 hours, then becomes lethargic, stops feeding, and has repeated vomiting with no fever. Ammonia level is markedly elevated. What is the most likely category of diagnosis, and why does the timing fit? Answer guidance: A urea cycle disorder (most commonly OTC deficiency). Symptoms appear once the infant starts protein feeding (breast milk or formula) and generates a nitrogen load the defective cycle cannot handle, so ammonia accumulates and produces lethargy, vomiting, and progresses toward encephalopathy.
-
A patient's routine blood panel shows markedly elevated ALT and AST. What does this tell you biochemically, and what does it not tell you about ammonia handling? Answer guidance: Elevated ALT/AST indicates hepatocyte membrane damage releasing intracellular transaminases into blood — it reflects liver cell injury, not urea cycle function directly. However, since the urea cycle occurs almost exclusively in the liver, severe hepatocellular damage can secondarily impair ureagenesis and raise ammonia too.
Analysis
-
Compare what happens to nitrogen if oxidative deamination occurs but the urea cycle is completely blocked, versus if oxidative deamination itself is blocked. Answer guidance: If deamination occurs but the urea cycle is blocked, free ammonia is generated normally but cannot be converted to urea, so ammonia accumulates in blood (hyperammonemia). If deamination itself is blocked, amino groups stay trapped on glutamate and are not released as free ammonia at all — ammonia levels would not rise from that route, though this scenario is far less clinically common than urea cycle enzyme defects.
-
Explain how fumarate produced in the urea cycle connects nitrogen metabolism to central carbon metabolism. Answer guidance: Argininosuccinase releases fumarate when cleaving argininosuccinate to arginine. Fumarate is a TCA cycle intermediate; it can be converted to malate then oxaloacetate, which can be transaminated back to aspartate. This aspartate can then re-enter the urea cycle as the second nitrogen donor, directly linking nitrogen disposal to the TCA cycle (sometimes called the "Krebs bicycle").
FAQ
1. Why can't the body just excrete ammonia directly instead of converting it to urea? Ammonia is small, highly diffusible, and directly toxic to the brain even at low micromolar concentrations — it disrupts neuronal energy metabolism and glutamate signaling. Urea is far less toxic, water-soluble, and can be safely concentrated by the kidney and excreted, which is why evolution favored converting ammonia to urea before excretion in mammals.
2. Where in the body does the urea cycle actually run? Almost exclusively in the liver. The first two steps (carbamoyl phosphate synthetase I and ornithine transcarbamylase) happen in the mitochondrial matrix of hepatocytes; the remaining three steps happen in the cytosol. This is why severe liver failure, not just genetic urea cycle enzyme defects, can also cause hyperammonemia.
3. Is glutamate dehydrogenase the only way ammonia enters the urea cycle? It is the major route, but glutamine also carries ammonia between tissues — peripheral tissues (like muscle) package ammonia as glutamine for safe transport to the liver, where glutaminase releases the ammonia again for urea cycle processing. This is clinically relevant because glutamine is used as a nontoxic ammonia shuttle in the bloodstream.
4. How does OTC deficiency differ from other urea cycle disorders in inheritance and presentation? OTC deficiency is X-linked recessive, making it the only urea cycle disorder with this inheritance pattern (the rest are autosomal recessive). This means male infants are typically affected more severely and present earlier, while carrier females can have milder, variable presentations depending on X-inactivation patterns.
5. Why do transaminase levels (ALT/AST) matter if they aren't part of the urea cycle itself? ALT and AST are the enzymes that funnel amino groups into the urea cycle's nitrogen pool by generating glutamate. Clinically they are used as liver injury markers because they leak from damaged hepatocytes, but biochemically their real job is amino acid catabolism — connecting protein breakdown to both energy metabolism (via keto acids like pyruvate and oxaloacetate) and nitrogen disposal.
Quick Revision
- Four levels of protein structure: primary (sequence), secondary (local folding), tertiary (3D shape), quaternary (multi-subunit assembly)
- Protein synthesis = transcription (DNA to mRNA) + translation (mRNA to protein)
- Protein degradation runs through the ubiquitin-proteasome pathway (tagged proteins) and lysosomal pathway (bulk turnover)
- Transamination moves amino groups (via ALT/AST, needs vitamin B6) without releasing free ammonia
- Oxidative deamination (glutamate dehydrogenase) is the main step that actually releases free NH3
- Urea cycle enzymes in order: CPS I, OTC, argininosuccinate synthetase, argininosuccinase, arginase
- CPS I is rate-limiting and requires N-acetylglutamate as an obligate activator
- Urea cycle combines one nitrogen from free NH3 and one from aspartate to make one urea molecule
- Fumarate released by argininosuccinase links the urea cycle back to the TCA cycle
- Urea cycle defects cause hyperammonemia; OTC deficiency (X-linked) is the most common
- Elevated ALT/AST signal hepatocyte injury, since the liver is where amino acid nitrogen is processed
- Insulin favors protein synthesis; glucagon and cortisol favor proteolysis and amino acid release
Related Topics
Prerequisites: Amino acid structure and classification, enzyme kinetics and cofactors, basic cell biology (nucleus, mitochondria, ribosomes)
Related Topics: Carbohydrate Metabolism (shared carbon-skeleton entry points into the TCA cycle), Lipid Metabolism (fed/fasted hormonal regulation parallels), Nucleotide Metabolism (another nitrogen-handling pathway)
Next Topics: Enzymes and Metabolism, Amino Acid Disorders (PKU, maple syrup urine disease), Clinical Biochemistry (interpreting liver panels and ammonia levels)
This page is for educational purposes. Always verify with current clinical guidelines.